The Emerging Role of Antineoplastic Agents in the Treatment of Keloids and Hypertrophic Scars
Autor: | Navin K. Singh, Gedge D. Rosson, Sachin M. Shridharani, Basak Basdag, Michael Magarakis, Paul N. Manson |
---|---|
Rok vydání: | 2010 |
Předmět: |
medicine.medical_specialty
Combination therapy Mitomycin Scars Antineoplastic Agents Bleomycin Wound irrigation Cicatrix chemistry.chemical_compound Patient satisfaction Humans Medicine business.industry Interferon-alpha Treatment options Hypertrophy Dermatology Surgery chemistry Keloid Etiology Fluorouracil Hypertrophic scars medicine.symptom business |
Zdroj: | Annals of Plastic Surgery. 64:355-361 |
ISSN: | 0148-7043 |
DOI: | 10.1097/sap.0b013e3181afaab0 |
Popis: | The management of keloids and hypertrophic scars continues to challenge health-care providers. Though both forms of pathologic scarring are distinct entities at the macro and microscopic level, their etiologies and treatment are often similar. Potential treatment approaches are progressing, and combinations of treatment options have been proposed in the literature with promising outcomes. The treatment evolution has reached a level where molecular therapeutic modalities are being investigated. Currently, no gold standard treatment exists. Overall success rates and patient satisfaction seem to be slowly climbing, but additional investigational studies must continue to be performed. Several studies have investigated antineoplastic agents, and there seems to be a marked improvement in rates of recurrence, patient satisfaction, and overall quality of scar when these agents are used. Intralesional injection and/or wound irrigation with interferon-a2b, interferon-g, mitomycin-C, bleomycin, or 5-fluorouracil seems to have a positive effect on the reduction of pathologic scars. There is mounting evidence that these drugs used alone or in combination therapy, have the potential to be an integral part of the treatment paradigm for hypertrophic scars and keloids. |
Databáze: | OpenAIRE |
Externí odkaz: |